Clinical Trial Update: Adjuvant Immunotherapy for Esophageal Squamous Cell Carcinoma [NA]

View source ↗

Summary

An update for a clinical trial investigating adjuvant immunotherapy for Esophageal Squamous Cell Carcinoma indicates the study is not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Esophageal Squamous Cell Carcinoma

Snippet

Sponsor: Sichuan University | Conditions: Esophageal Squamous Cell Carcinoma (ESCC) | NA | Status: NOT_YET_RECRUITING